CENTOGENE and Amarey Nova Medical Group launch exclusive collaboration to promote genetic testing in Colombia
Centogene AG (CENTOGENE) and Amarey Nova Medical Group (Amarey) are pleased to announce a strategic exclusive partnership in Colombia, as of September 2015.
Amarey is well-established as a distributor of pharmaceuticals, medical equipment, and devices with more than 30 years’ experience in the Colombian market. Its CEO, Mr. Octavio Amaya, was the visionary who founded the company in 1984. In the past three decades Amarey has attained many successes in the healthcare sector of Colombia and has been able to exclusively represent leading brands such as Roche, Biotest, Chiesi, Intuitive, Nihon Kohden, and Stryker by building long lasting relationships.
CENTOGENE as the worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio comprising more than 2,800 genes, has revolutionized clinical interpretation with highest medical quality.
The strategic alliance with Amarey will enable both partners to bring the benefits of early and comprehensive diagnosis of hereditary diseases to the Colombian population and to bring patients closer to
proper diagnosis and effective treatment.
It is of the upmost importance to Amarey and CENTOGENE to help Colombian patients have a better
quality of life and be able to access the best technologies available worldwide. This motivation is something that is inherent in the organization of both companies and will continue to be supported by educational to train both patients and medical groups towards the management of hereditary and rare diseases that are not as well-known.